Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: A comparison study

Photodermatology Photoimmunology and Photomedicine

Volumn 18, Issue 5, 2002, Pages 217-222

  Breuckmann, F ^a   Von Kobyletzki, G ^a   Avermaete, A ^a   Kreuter, A ^a   Altmeyer, P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Apoptosis; Atopic dermatitis (AD); bcl 2; Cutaneous T cell lymphoma (CTCL); UVA1 phototherapy

Indexed keywords

APOPTOSIS INHIBITOR; EMOLLIENT AGENT; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CUTANEOUS T CELL LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUNCH BIOPSY; RADIATION DOSE; SKIN BIOPSY; SKIN DISEASE; TREATMENT OUTCOME; BIOPSY; CD4 LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; RADIATION EXPOSURE; SKIN; STATISTICAL MODEL;

APOPTOSIS; BIOPSY; CD4 LYMPHOCYTE COUNT; DERMATITIS, ATOPIC; HUMANS; LINEAR MODELS; LYMPHOMA, T-CELL, CUTANEOUS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0036810118     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2002.02740.x     Document Type: Article

References (24)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96: 302-319.
2. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97: 389-394.
3. Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. N Engl J Med 1981; 304: 1319-1323.
4. Weiss LM, Hu E, Wood GS, et al. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 1985; 313: 539-544.
5. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-689.
6. Kaye FJ, Bunn PA, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1784-1790.
7. Rook AH, Prystowsky MB, Cassin M, Boufal M, Lessin SR. Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observation. Arch Dermatol 1991; 127: 1535-1540.
8. Kobyletzki G, Kreuter JA, Nordmeier R, Stücker M, Altmeyer P. Treatment of idiopathic mucinosis follicularis with UV-A1 cold light phototherapy. Dermatology 2000; 201: 76.
9. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. High-dose UV-A1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
10. Meffert H, Sönnichsen N, Herzog M, Hutschenreuther A. UV-A1 cold light treatment of acute exacerbated atopic dermatitis. Dermatol Monatsschr 1992; 78: 291-296.
11. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768.
12. Francz PI, Conrad J, Biesalski HK. Modulation of UV-A-induced lipid peroxidation and suppression of UV-B-induced ornithine decarboxylase response by all-trans-retinoic acid in human skin fibroblasts in vitro. Biol Chem 1998; 379: 1263-1269.
13. Grether-Beck S, Olaizola-Horn S, Schmitt H, et al. Activation of transcription factor AP2 mediates ultraviolet A radiation and singlet oxygen induced expression of the human ICAM-1 gene. Proc Natl Acad Sci USA 1996; 93: 14586-14591.
14. Morlière P, Moysan A, Tirache I. Action spectrum for UV-induced lipid peroxidation in cultured human skin fibroblasts. Free Radic Biol Med 1995; 19: 365-371.
15. Godar DE, Miller SA, Thomas DP. Immediate and delayed apoptotic cell death mechanisms: UV-A versus UV-B and UV-C irradiation. Cell Death Different 1994; 1: 59-66.
16. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980; 92: 44-47.
17. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
18. Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P. Medium-dose UV-A1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999; 41: 931-937.
19. Kobyletzki G, Freitag M, Dirschka T, Hoffmann K, Altmeyer P. UV-A1 cold light phototherapy improves skin condition even in advanced stage of cutaneous T-cell lymphoma. J EADV 1998; 11 (Suppl 2): 319.
20. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-779.
21. Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331-1341.
22. Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis. multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 1997; 186: 25-37.
23. Pourzand C, Rossier G, Reelfs O, Borner C, Tyrrel RM. The overexpression of bcl-2 inhibits UVA-mediated immediate apoptosis in rat 6 fibroblasts: evidence for the involvement of bcl-2 as an antioxidant. Cancer Res 1997; 57: 1405-1411.
24. Breuckmann F, Kreuter A, Wotzlaw C, Altmeyer P, von Kobyletzki G. Increased expression of bcl-2 provides inflammation in atopic dermatitis and cutaneous T-cell lymphoma in vivo. JEADV 2000; 14 (Suppl 1): 122.